Previous 10 | Next 10 |
2023-11-02 21:11:03 ET Cardiff Oncology, Inc. (CRDF) Q3 2023 Earnings Conference Call November 02, 2023, 16:30 ET Company Participants Kiki Patel - IR, Gilmartin Group Mark Erlander - CEO Jamie Levine - CFO Conference Call Participants Mark Frahm - TD...
2023-11-02 16:42:20 ET More on Cardiff Oncology Cardiff Oncology (CRDF) Investor Presentation - Slideshow Cardiff Oncology: How The Recommitment Shapes The Investment Thesis (Rating Upgrade) Biggest stock movers today: Cloudflare, NextEra Energy Partners, ChargePoint...
Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update PR Newswire - Advance to first-line RAS-mutated metastatic colorectal cancer (mCRC) for lead program based on positive clinical and preclinical data and guidance from FDA - - Expanded rela...
Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...
Cardiff Oncology Inc. (CRDF) is expected to report $-0.29 for Q3 2023
Cardiff Oncology to Report Third Quarter 2023 Financial Results and Provide Business Update PR Newswire - Management will hold a conference call on Thursday, November 2 at 4:30 p.m. ET / 1:30 p.m. PT - SAN DIEGO , Oct. 26, 2023 /PRNewswire/ --...
2023-10-23 08:45:38 ET Palm Beach, FL – October 23, 2023 – FinancialNewsMedia.com News Commentary – Pancreatic ductal adenocarcinoma (PDAC) is a fatal malignancy of both the digestive system and endocrine system with disappointing prognoses. The number of ne...
2023-09-28 08:24:45 ET More on Ascent Solar Technologies, Cardiff Oncology, etc. Cardiff Oncology (CRDF) Investor Presentation - Slideshow Cardiff Oncology: How The Recommitment Shapes The Investment Thesis (Rating Upgrade) Biggest stock movers today: Cloudflare, Nex...
2023-09-27 09:55:35 ET DENVER, Colo., Sept 27, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; ShiftPixy Inc (NASDAQ: PIXY), Galecto Inc (NASDAQ: GLTO), Cardiff Oncology Inc (NASDAQ: CRDF), American Strat...
2023-09-27 07:42:23 ET (24/7 MARKET NEWS) – Cardiff Oncology, Inc. (NASDAQ: CRDF) reported, after yesterday’s market close, positive clinical data with onvansertib monotherapy and combination therapy in our ongoing trials in metastatic pancreatic ductal adenocarcinoma (mPDAC) ...
News, Short Squeeze, Breakout and More Instantly...
Cardiff Oncology Inc. Company Name:
CRDF Stock Symbol:
NASDAQ Market:
Cardiff Oncology Inc. Website:
SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will present at two upcoming investor conferences in M...
- In RAS-mutated mCRC, clinical data from ONSEMBLE trial, and preclinical data presented at AACR, demonstrated strong efficacy signal in bev naïve patients and support ongoing first-line RAS-mutated mCRC lead program - - In RAS wild-type mCRC, preclinical data presented at AACR dem...